CURRICULUM VITAE

Date prepared: 7/05

**NAME:** William H. Maisel, MD, MPH

**ADDRESS:** **Office:**

> Cardiovascular Division, Beth Israel Deaconess Medical Center
>
> 185 Pilgrim Road, Baker 4, Boston, MA 02215 Phone: (617) 632-7457

Fax: (617) 632-7620

**EDUCATION:**

B.S., Biology Massachusetts Institute of Technology,

Cambridge, MA

M.D. Cornell University Medical College,

New York, NY

M.P.H. Harvard School of Public Health,

Boston, MA

**POSTDOCTORAL TRAINING:**

Internal Medicine Internship**,** Brigham and Women's Hospital, Boston,
MA

> Internal Medicine Residency, Brigham and Women's Hospital, Boston, MA
>
> Cardiovascular Fellowship, Brigham and Women's Hospital, Boston, MA
>
> Cardiac Electrophysiology Fellowship, Brigham and Women's Hospital,
> Boston, MA

Clinical Fellow in Medicine, Harvard Medical School, Boston, MA

# LICENSURE AND CERTIFICATION

National Board of Medical Examiners

Massachusetts License Registration

American Board of Internal Medicine

> American Board of Internal Medicine, Cardiovascular Disease
>
> American Board of Internal Medicine, Clinical Cardiac
> Electrophysiology

**ACADEMIC APPOINTMENTS**

> Assistant Professor of Medicine, Harvard Medical School, Boston, MA

**HOSPITAL APPOINTMENTS**

> Attending Staff Physician, Cardiovascular Division,
>
> Beth Israel Deaconess Medical Center, Boston, MA

**MEMBERSHIP IN PROFESSIONAL SOCIETIES**

Massachusetts Medical Society

American College of Cardiology

> American Medical Association

American Heart Association

Heart Rhythm Society

## AD HOC REVIEWER

American Journal of Cardiology

Annals of Internal Medicine

Circulation

Journal of the American College of Cardiology

Journal of Cardiovascular Electrophysiology

Journal of Interventional Cardiac Electrophysiology

New England Journal of Medicine

Pacing and Clinical Electrophysiology

**[BIBLIOGRAPHY]{.underline}**

## 

## ORIGINAL ARTICLES

1.  **Maisel WH**, Kuntz KM, Reimold SC, Lee TH, Antman EM, Friedman PL,
    Stevenson WG. Risk of Initiating Antiarrhythmic Drug Therapy for
    Atrial Fibrillation in Patients Admitted to a University Hospital.
    Ann Intern Med 1997; 127: 281-284.

2.  Reimold SC, **Maisel WH**, Antman EM. Propafenone for the Treatment
    of Supraventricular Tachycardia and Atrial Fibrillation: A
    Meta-Analysis. Am J Cardiol 1998; 82: 66N-71N.

3.  **Maisel WH**, Lukanich JM, Bueno R, Friedman PL, Reimold SC. Left
    Ventricular Pseudoaneurysm Following Implantable
    Cardioverter-Defibrillator with Epicardial Patch Electrodes. Ann
    Thorac Surg 1998; 66: 2102-4.

4.  Delacretaz E, Stevenson WG, Ellison KE, **Maisel WH**, Friedman PL.
    Mapping and Radiofrequency Catheter Ablation of the Three Types of
    Sustained Monomorphic Ventricular Tachycardia in Nonischemic Heart
    Disease. J Cardiovasc Electrophysiol 2000; 11: 11-17.

5.  Soejima K, Stevenson WG, Delacretaz E, Brunckhorst CB, **Maisel
    WH**, Friedman PL. Identification of Left Atrial Origin of Ectopic
    Tachycardia During Right Atrial Mapping: Analysis of Double
    Potentials at the Posteromedial Right Atrium. J Cardiovasc
    Electrophysiol 2000; 11: 975-980.

6.  **Maisel WH**, Sweeney MO, Stevenson WG, Ellison KE, Epstein LM.
    Recalls and Safety Alerts Involving Pacemakers and Implantable
    Cardioverter-Defibrillator Generators. JAMA 2001; 286: 793-799.

7.  **Maisel WH**, Stevenson WG, Tung S, Blier LE, Brunckhorst CB. Less
    is More - 4:2:1 Block. Circulation 2001; 104: E50.

8.  Soejima K, Delacretaz E, Suzuki M, Brunckhorst CB, **Maisel WH**,
    Friedman PL, Stevenson WG. Saline-Cooled Versus Standard
    Radiofrequency Catheter Ablation for Infarct-Related Ventricular
    Tachycardia. Circulation 2001; 103: 1858-1862.

9.  Soejima K, Stevenson WG, **Maisel WH**, Delacretaz E, Brunckhorst
    CB, Ellison KE, Friedman PL. The N + 1 Difference: A New Measure for
    Entrainment Mapping. J Am Coll Cardiol 2001; 37: 1386-94.

10. Soejima K, Suzuki M, **Maisel WH**, Brunckhorst CB, Delacretaz E,
    Blier L, Tung S, Khan H, Stevenson WG. Catheter Ablation in Patients
    with Multiple and Unstable Ventricular Tachycardias After Myocardial
    Infarction: Short Ablation Lines Guided by Reentry Circuit Isthmuses
    and Sinus Rhythm Mapping. Circulation 2001; 104: 664-669.

11. Khan HH, **Maisel WH**, Ho C, Sukuki M, Soejima K, Solomon S,
    Stevenson WG. Effect of Radiofrequency Catheter Ablation of
    Ventricular Tachycardia on Left Ventricular Function in Patients
    With Prior Myocardial Infarction. J Intervent Card Electrophsiol
    2002; 7: 243-7.

12. Soejima K, Stevenson WG, **Maisel WH**, Sapp JL, Epstein LM.
    Electrically Unexcitable Scar Mapping Based on Pacing Threshold for
    Identification of the Reentry Circuit Isthmus: Feasibility for
    Guiding Ventricular Tachycardia Ablation. Circulation 2002; 106:
    1678-1683.

13. **Maisel WH**, Stevenson WG, Epstein LM. Reduced Atrial Blood Flow
    in Patients With Coronary Artery Disease. Coronary Artery Disease
    2002; 13: 283-290.

14. **Maisel WH**, Stevenson WG, Epstein LM. Changing Trends in
    Pacemaker and Implantable-Cardioverter Defibrillator Generator
    Advisories. Pacing and Clinical Electrophysiology 2002; 25: 1670-8.

15. Koplan BA, Stevenson WG, Epstein LM, Aranki S, **Maisel WH**.
    Development and Validation of a Simple Risk Score to Predict the
    Need for Permanent Pacing After Cardiac Valve Surgery. J Am Coll
    Cardiol 2003; 41: 795-801.

16. Brunckhorst CB, Stevenson WG, Soejima K, **Maisel WH**, Delacretaz
    E, Friedman PL, Ben-Haim SA. Relationship of Slow Conduction
    Detected by Pace-Mapping to Ventricular Tachycardia Reentry Circuits
    Sites After Infarction. J Am Coll Cardiol 2003; 41: 802-809.

17. Tung S, Soejima K, **Maisel WH**, Suzuki M, Epstein L, Stevenson WG.
    Recognition of Far-Field Electrograms During Entrainment Mapping of
    Ventricular Tachycardia. J Am Coll Cardiol 2003; 42: 110-115.

18. Delacretaz E, Soejima K, Brunckhorst C, **Maisel WH**, Friedman PL,
    Stevenson WG. Assessment of Radiofrequency Ablation Effect From
    Unipolar Pacing Threshold. Pacing and Clinical Electrophysiology
    2003; 26: 1993-96.

19. **Maisel WH**. Physician Management of Pacemaker and Implantable
    Cardioverter-Defibrillator Advisories. Pacing and Clinical
    Electrophysiology 2004; 27: 437-442.

20. Brunckhorst CB, Delacretaz E, Soejima K, **Maisel WH**, Friedman PL,
    Stevenson WG. Identification of the Ventricular Tachycardia Isthmus
    after Infarction by Pace-Mapping. Circulation 2004; 110: 652-59.

21. Desai AS, Fang JC, **Maisel WH**, Baughman KL. Implantable
    Defibrillators for the Prevention of Mortality in Patients with
    Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled
    Trials. JAMA 2004; 292:2874-2879.

22. Lopera G, Stevenson WG, Soejima K, **Maisel WH**, Koplan B, Sapp JL,
    Satti SD, Epstein LM. Identification and Ablation of Three Types of
    Ventricular Tachycardia Involving the His-Purkinje System in
    Patients with Heart Disease. J Cardiovasc Electrophysiol 2004;15:
    52-8.

23. Tedrow U, **Maisel WH**, Epstein LM, Soejima K, Stevenson WG.
    Feasibility of Adjusting Paced Left Ventricular Activation by
    Manipulating Stimulus Strength. J Am College of Cardiol 2004; 44:
    2249-52.

24. Brunckhorst CB, Delacretaz, E, Soejima K, Maisel WH, Friedman PL,
    Stevenson WG. Impact of changing activation sequence on bipolar
    electrogram amplitude for voltage mapping of left ventricular
    infarcts causing ventricular tachycardia. J Interv Card
    Electrophysiol. 2005;12: 137-41.

## CHAPTERS/EDITORIALS/REVIEWS

1.  **Maisel WH**, Stevenson WG. How Risky is Initiation of
    Antiarrhythmic Therapy for Atrial Fibrillation? Cardiology Review
    1998; 15(3): 29-34.

2.  **Maisel WH**, Friedman PL. Esmolol and Other Intravenous
    Beta-Blockers. Cardiac Electrophysiology Review 1998; 2: 170-172.

3.  **Maisel WH**, Stevenson WG. Sudden Death and the
    Electrophysiological Effects of Angiotensin-Converting Enzyme
    Inhibitors. J Cardiac Failure 2000; 6: 80-82.

4.  **Maisel WH**, Stevenson WG. Diagnosing Syncope in the Emergency
    Department. Fam Pract Recert 2000; 22: 62-74.

5.  **Maisel WH**, Rawn JD, Stevenson WG. Atrial Fibrillation After
    Cardiac Surgery. Ann Intern Med 2001; 135: 1061-1073.

6.  Stevenson WG, **Maisel WH**. ECG Artifact: What you do not know, you
    do not recognize. Am J Med 2001; 110: 402-3.

7.  Stevenson WG, Ellison KE, Sweeney MO, Epstein LM, **Maisel WH**.
    Management of Arrhythmias in Heart Failure. Cardiol Rev 2002; 10:
    8-14.

8.  **Maisel WH**, Stevenson WG, Epstein LM. Safety of Implantable
    Cardiac Devices. JAMA 2002; 287: 839-840.

9.  **Maisel WH**. Warfarin vs. Antiplatelet Agents for Non-Rheumatic
    Atrial Fibrillation. J Watch Neurol 2002; 4: 25-26.

10. Stevenson WG, Epstein LM, **Maisel WH**, Sweeney, MO, Stevenson LW.
    Arrhythmias in Heart Failure. Futura Publishing Company, Inc,
    Armonk, NY, 2002.

11. **Maisel WH**. Increased Failure Rate of a Polyurethane ICD Lead.
    Pacing Clin Electrophysiol 2002; 25: 877-78.

12. **Maisel WH**, Stevenson WG. Syncope - Getting to the Heart of the
    Matter. N Engl J Med 2002; 347: 931-933.

13. Shea JB, **Maisel WH**. Cardiology Patient Pages. Cardioversion.
    Circulation 2002; 106: e176-e178.

14. **Maisel WH**. Pacemaker and Implantable Cardioverter-Defibrillator
    Generator Recalls and Safety Alerts: Rates, Trends, and
    Implications. CVR&R 2002; 23: 684-688.

15. **Maisel WH**. Approach to the Patient With Syncope. In: Irwin RS,
    Rippe JM, editors. Irwin and Rippe's Intensive Care Medicine, 5^th^
    Ed. Philadelphia: Lippincott Williams & Wilkins, 2003: 358-66.

16. **Maisel WH**, Stevenson LW. Atrial Fibrillation in Heart Failure:
    Epidemiology, Pathophysiology and Rationale for Therapy. Am J
    Cardiol 2003; 91(suppl): 2D-8D.

17. Ellison KE, Stevenson WG, Sweeney MO, Epstein LM, **Maisel WH**.
    Management of arrhythmias in heart failure. Congestive Heart Failure
    2003; 9:91-9.

18. **Maisel WH**. Impact of Expanding Indications on the Safety of
    Pacemakers and Defibrillators. Cardiac Electrophysiol Rev 2003; 7:
    30-32.

19. **Maisel WH.** Autonomic Modulation Preceding the Onset of Atrial
    Fibrillation. J Amer Coll Cardiol 2003; 42: 1269-70.

20. **Maisel WH.** Medical Device Regulation: An Introduction for the
    Practicing Physician. Ann Intern Med 2004; 296-302.

21. **Maisel WH**. Specialized Syncope Evaluation. Circulation 2004;
    110: 3621-23.

22. **Maisel WH**. Report from the Meeting of the Circulatory System
    Devices Panel of the Food and Drug Administration, Center for
    Devices and Radiologic Health, September 21, 2004. Circulation 2005;
    111: 2143-5.

23. **Maisel WH**. Cardiovascular Device Development: Lessons Learned
    from Pacemaker and Implantable Cardioverter-Defibrillator Therapy.
    Am J Ther 2005; 12: 183-5.

24. **Maisel WH**, Laskey WK. Patent Foramen Ovale Closure Devices:
    Moving Beyond Equipoise. JAMA 2005; 25: 294; 366-9.